Metabotropic glutamate receptor-4 modulates adaptive immunity and restrains neuroinflammation

Francesca Fallarino, Claudia Volpi, Francesco Fazio, Serena Notartomaso, Carmine Vacca, Carla Busceti, Silvio Bicciato, Giuseppe Battaglia, Valeria Bruno, Paolo Puccetti, Maria C. Fioretti, Ferdinando Nicoletti, Ursula Grohmann, Roberto Di Marco

Research output: Contribution to journalArticle

92 Citations (Scopus)

Abstract

High amounts of glutamate are found in the brains of people with multiple sclerosis, an inflammatory disease marked by progressive demyelination. Glutamate might affect neuroinflammation via effects on immune cells. Knockout mice lacking metabotropic glutamate receptor-4 (mGluR4) were markedly vulnerable to experimental autoimmune encephalomyelitis (EAE, a mouse model of multiple sclerosis) and developed responses dominated by interleukin-17-producing T helper (TH17) cells. In dendritic cells (DCs) from those mice, defective mGluR4 signaling-which would normally decrease intracellular cAMP formation-biased TH cell commitment to the TH 17 phenotype. In wild-type mice, mGluR4 was constitutively expressed in all peripheral DCs, and this expression increased after cell activation. Treatment of wild-type mice with a selective mGluR4 enhancer increased EAE resistance via regulatory T (Treg) cells. The high amounts of glutamate in neuroinflammation might reflect a counterregulatory mechanism that is protective in nature and might be harnessed therapeutically for restricting immunopathology in multiple sclerosis.

Original languageEnglish (US)
Pages (from-to)897-902
Number of pages6
JournalNature Medicine
Volume16
Issue number8
DOIs
StatePublished - Aug 1 2010
Externally publishedYes

Fingerprint

Adaptive Immunity
Multiple Sclerosis
Glutamic Acid
Regulatory T-Lymphocytes
Dendritic Cells
Th17 Cells
Autoimmune Experimental Encephalomyelitis
Interleukin-17
Demyelinating Diseases
Helper-Inducer T-Lymphocytes
Knockout Mice
Brain
Chemical activation
Phenotype
metabotropic glutamate receptor 4

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Fallarino, F., Volpi, C., Fazio, F., Notartomaso, S., Vacca, C., Busceti, C., ... Di Marco, R. (2010). Metabotropic glutamate receptor-4 modulates adaptive immunity and restrains neuroinflammation. Nature Medicine, 16(8), 897-902. https://doi.org/10.1038/nm.2183

Metabotropic glutamate receptor-4 modulates adaptive immunity and restrains neuroinflammation. / Fallarino, Francesca; Volpi, Claudia; Fazio, Francesco; Notartomaso, Serena; Vacca, Carmine; Busceti, Carla; Bicciato, Silvio; Battaglia, Giuseppe; Bruno, Valeria; Puccetti, Paolo; Fioretti, Maria C.; Nicoletti, Ferdinando; Grohmann, Ursula; Di Marco, Roberto.

In: Nature Medicine, Vol. 16, No. 8, 01.08.2010, p. 897-902.

Research output: Contribution to journalArticle

Fallarino, F, Volpi, C, Fazio, F, Notartomaso, S, Vacca, C, Busceti, C, Bicciato, S, Battaglia, G, Bruno, V, Puccetti, P, Fioretti, MC, Nicoletti, F, Grohmann, U & Di Marco, R 2010, 'Metabotropic glutamate receptor-4 modulates adaptive immunity and restrains neuroinflammation', Nature Medicine, vol. 16, no. 8, pp. 897-902. https://doi.org/10.1038/nm.2183
Fallarino, Francesca ; Volpi, Claudia ; Fazio, Francesco ; Notartomaso, Serena ; Vacca, Carmine ; Busceti, Carla ; Bicciato, Silvio ; Battaglia, Giuseppe ; Bruno, Valeria ; Puccetti, Paolo ; Fioretti, Maria C. ; Nicoletti, Ferdinando ; Grohmann, Ursula ; Di Marco, Roberto. / Metabotropic glutamate receptor-4 modulates adaptive immunity and restrains neuroinflammation. In: Nature Medicine. 2010 ; Vol. 16, No. 8. pp. 897-902.
@article{5529b7ea3a8a416ca2ff0a64e285c07d,
title = "Metabotropic glutamate receptor-4 modulates adaptive immunity and restrains neuroinflammation",
abstract = "High amounts of glutamate are found in the brains of people with multiple sclerosis, an inflammatory disease marked by progressive demyelination. Glutamate might affect neuroinflammation via effects on immune cells. Knockout mice lacking metabotropic glutamate receptor-4 (mGluR4) were markedly vulnerable to experimental autoimmune encephalomyelitis (EAE, a mouse model of multiple sclerosis) and developed responses dominated by interleukin-17-producing T helper (TH17) cells. In dendritic cells (DCs) from those mice, defective mGluR4 signaling-which would normally decrease intracellular cAMP formation-biased TH cell commitment to the TH 17 phenotype. In wild-type mice, mGluR4 was constitutively expressed in all peripheral DCs, and this expression increased after cell activation. Treatment of wild-type mice with a selective mGluR4 enhancer increased EAE resistance via regulatory T (Treg) cells. The high amounts of glutamate in neuroinflammation might reflect a counterregulatory mechanism that is protective in nature and might be harnessed therapeutically for restricting immunopathology in multiple sclerosis.",
author = "Francesca Fallarino and Claudia Volpi and Francesco Fazio and Serena Notartomaso and Carmine Vacca and Carla Busceti and Silvio Bicciato and Giuseppe Battaglia and Valeria Bruno and Paolo Puccetti and Fioretti, {Maria C.} and Ferdinando Nicoletti and Ursula Grohmann and {Di Marco}, Roberto",
year = "2010",
month = "8",
day = "1",
doi = "10.1038/nm.2183",
language = "English (US)",
volume = "16",
pages = "897--902",
journal = "Nature Medicine",
issn = "1078-8956",
publisher = "Nature Publishing Group",
number = "8",

}

TY - JOUR

T1 - Metabotropic glutamate receptor-4 modulates adaptive immunity and restrains neuroinflammation

AU - Fallarino, Francesca

AU - Volpi, Claudia

AU - Fazio, Francesco

AU - Notartomaso, Serena

AU - Vacca, Carmine

AU - Busceti, Carla

AU - Bicciato, Silvio

AU - Battaglia, Giuseppe

AU - Bruno, Valeria

AU - Puccetti, Paolo

AU - Fioretti, Maria C.

AU - Nicoletti, Ferdinando

AU - Grohmann, Ursula

AU - Di Marco, Roberto

PY - 2010/8/1

Y1 - 2010/8/1

N2 - High amounts of glutamate are found in the brains of people with multiple sclerosis, an inflammatory disease marked by progressive demyelination. Glutamate might affect neuroinflammation via effects on immune cells. Knockout mice lacking metabotropic glutamate receptor-4 (mGluR4) were markedly vulnerable to experimental autoimmune encephalomyelitis (EAE, a mouse model of multiple sclerosis) and developed responses dominated by interleukin-17-producing T helper (TH17) cells. In dendritic cells (DCs) from those mice, defective mGluR4 signaling-which would normally decrease intracellular cAMP formation-biased TH cell commitment to the TH 17 phenotype. In wild-type mice, mGluR4 was constitutively expressed in all peripheral DCs, and this expression increased after cell activation. Treatment of wild-type mice with a selective mGluR4 enhancer increased EAE resistance via regulatory T (Treg) cells. The high amounts of glutamate in neuroinflammation might reflect a counterregulatory mechanism that is protective in nature and might be harnessed therapeutically for restricting immunopathology in multiple sclerosis.

AB - High amounts of glutamate are found in the brains of people with multiple sclerosis, an inflammatory disease marked by progressive demyelination. Glutamate might affect neuroinflammation via effects on immune cells. Knockout mice lacking metabotropic glutamate receptor-4 (mGluR4) were markedly vulnerable to experimental autoimmune encephalomyelitis (EAE, a mouse model of multiple sclerosis) and developed responses dominated by interleukin-17-producing T helper (TH17) cells. In dendritic cells (DCs) from those mice, defective mGluR4 signaling-which would normally decrease intracellular cAMP formation-biased TH cell commitment to the TH 17 phenotype. In wild-type mice, mGluR4 was constitutively expressed in all peripheral DCs, and this expression increased after cell activation. Treatment of wild-type mice with a selective mGluR4 enhancer increased EAE resistance via regulatory T (Treg) cells. The high amounts of glutamate in neuroinflammation might reflect a counterregulatory mechanism that is protective in nature and might be harnessed therapeutically for restricting immunopathology in multiple sclerosis.

UR - http://www.scopus.com/inward/record.url?scp=77955394778&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77955394778&partnerID=8YFLogxK

U2 - 10.1038/nm.2183

DO - 10.1038/nm.2183

M3 - Article

C2 - 20657581

AN - SCOPUS:77955394778

VL - 16

SP - 897

EP - 902

JO - Nature Medicine

JF - Nature Medicine

SN - 1078-8956

IS - 8

ER -